AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2026
Feb 6, 2026
35200_dirs_2026-02-06_ebd6b43c-5853-4f59-9cd1-337be83e5cb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2026-02-04
Reporting Person: Ho William Tai-Wei (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | Employee Stock Option (right to buy) | $1.96 | A | 206000 | Acquired | 2036-02-04 | Common Stock (206000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.